Right Test, Right Time: Integrating Imaging, Tissue, and Specialized Biomarkers in Hepatology

Nov 07 2026
Convention Center: Bluebird Ballroom 2DEF
2:00 PM - 3:30 PM
Captured/recorded session Recorded
CE Credits CE Credits

Description

Accurate liver diagnosis demands confident imaging interpretation, selective biopsy use, and smart application of specialized tests. This case-based session delivers practical skills in 3 areas: (1) radiology for nonradiologists; (2) biopsy in the era of noninvasive tests; and (3) uncommon diagnostics. Attendees gain actionable checklists, algorithms, and strategies for immediate clinical application. Designed for hepatology clinicians and multidisciplinary teams, this session emphasizes real-world decision-making and interactive questions and answers.  

Presentations

2:00 PM - 2:25 PM
Convention Center - Bluebird Ballroom 2DEF
Recorded session

From Pixels to Practice: What Matters Most on Liver Imaging

Yuko Kono, MD, PhD, FAASLD | Presenter
2:25 PM - 2:50 PM
Convention Center - Bluebird Ballroom 2DEF
Recorded session

Back to Basics: When the Slide Still Speaks Louder Than the Scores

Sadhna Dhingra, MBBS, MD, FCAP | Presenter
2:50 PM - 3:10 PM
Convention Center - Bluebird Ballroom 2DEF
Recorded session

Precision Power Tools: When Specialized Tests Transform the Diagnosis

Mikhail Alper, PA-C, AF-AASLD | Presenter
3:10 PM - 3:30 PM
Convention Center - Bluebird Ballroom 2DEF
Recorded session

Panel Discussion and Question-and-Answer Period

Allysa Saggese, MSN, AGPCNP-BC | Moderator

Objectives

  • Interpret the critical elements of liver imaging reports and apply appropriate liverspecific imaging protocols and contrast choices to common clinical scenarios.
  • Differentiate when liver biopsy is indicated in the context of noninvasive testing and recognize key histologic features that influence management.
  • Select and interpret uncommon diagnostic tests (eg, genetic panels, alpha-fetoprotein-L3/protein induced by vitamin K absence-II [AFP-L3/PIVKAII], primary biliary cholangitisspecific antinuclear antibodies [PBCspecific ANA]) and incorporate results into patientcentered diagnostic algorithms.